Single-Photon Emission Computed Tomography SPECT Market Size
Medical Equipment

What Will The Single-Photon Emission Computed Tomography SPECT Market Look Like In 2023?

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s single-photon emission computed tomography SPECT market report forecasts the single-photon emission computed tomography SPECT market size to grow to $3.04 Billion by 2027, with a CAGR (compound annual growth rate) of more than 7%.

Learn More On The Single-Photon Emission Computed Tomography SPECT Market Report 2023 – https://www.thebusinessresearchcompany.com/report/single-photon-emission-computed-tomography-spect-global-market-report

Single-Photon Emission Computed Tomography SPECT Market Size Forecast
The global single-photon emission computed tomography SPECT market is expected to grow from $2.13 billion in 2022 to $2.27 billion in 2023 at a compound annual growth rate (CAGR) of 6.75%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global single-photon emission computed tomography (SPECT) market size is expected to reach $3.04 billion in 2027 at a CAGR of 7.52%.

North America held the largest single-photon emission computed tomography SPECT market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Single-Photon Emission Computed Tomography SPECT Market Driver ­– Rise In The Prevalence Of Cases Of Cancer
According to a research article published in December 2020 by the International Agency for Research on Cancer (IARC), a France-based intergovernmental agency and part of the World Health Organisation, 19.3 million new cancer cases were reported in 2020, with cancer accounting for 10 million deaths. Female breast cancer will be the most common cancer worldwide, followed by lung, colorectal, prostate, and stomach cancers. As a result, the rising prevalence of cancer cases is propelling the single-photon emission computed tomography (SPECT) market forward.

Request for A Sample Of The Global Single-Photon Emission Computed Tomography SPECT Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9960&type=smp

Key Single-Photon Emission Computed Tomography SPECT Market Trend – Technological Advancement
Companies in the single-photon emission computed tomography (SPECT) industry are embracing new technologies such as high-resolution imaging to maintain their market position. For example, Siemens Healthcare, a medical device and medical solution manufacturing firm based in Germany, will release the Symbia Pro. Spectra SPECT/CT Scanner in June 2022. This Symbia Pro. Spectra SPECT/CT system features enhanced imaging technology, increased accessibility, excellent low-dose imaging, automated SPECT motion correction, and customised clinical tools tailored for imaging applications in cardiology, oncology, orthopaedics, and neurology. This gadget also has myExam Companion, which allows for automatic workflow guidance.

Single-Photon Emission Computed Tomography SPECT Market Segment
1) By Type: Hybrid SPECT Systems, Standalone SPECT Systems
2) By Type Of Radioisotopes: Tc-99m, Ra-223, Ga-67, I-123, Other Radioisotopes
3) By Application: Oncology, Cardiology, Neurology, Other Applications
4) By End User: Hospitals, Diagnostic Centers, Other End User

Single-Photon Emission Computed Tomography SPECT Market Major Players and Strategies
Major players in the single-photon emission computed tomography SPECT market are GE HealthCare Technologies Inc., Siemens Healthineers, Bruker Corporation, Digirad Corporation, Mediso Ltd., DDD-Diagnostic A/S, Bracco Diagnostic Imaging, Cardinal Health Inc., Curium Pharma, Spectrum Dynamics Medical, Koninklijke Philips N.V., Beijing Hamamatsu Photon Techniques Inc., Novartis AG, MIE Medical Imaging Electronics GmbH and Global Medical Solutions Private Limited.

GE Healthcare, a medical technology business based in the United States, acquired Prismatic Sensors for an unknown sum in November 2020. GE Healthcare will be able to leverage deep silicon detector technology for photon counting computed tomography (PCCT) of prismatic sensors as a result of this acquisition. GE Healthcare will be able to increase its clinical capabilities, gain comprehensive visualisation of organ architecture, and improve tissue characterization thanks to this cutting-edge technology. Prismatic Sensors is a Swedish start-up that specialises in the production of photon-counting detectors.

The Single-Photon Emission Computed Tomography SPECT Global Market Report 2023 covers regional data on single-photon emission computed tomography SPECT market size, single-photon emission computed tomography SPECT market trends and drivers, opportunities, strategies, and single-photon emission computed tomography SPECT market competitor analysis. The countries covered in the single-photon emission computed tomography SPECT market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Single-photon emission computed tomography (SPECT) is a medical imaging technology that produces 3D images of inside organs and tissues using radioactive tracers and gamma rays. By generating gamma rays, the tracer can be detected by a gamma camera, allowing for non-invasive and detailed imaging of a patient’s interior structure.

View More Reports Related To The Single-Photon Emission Computed Tomography SPECT Market –
Computed Tomography (CT) Scanners Devices And Equipment Global Market Report 2023
Single Family Smart Homes Global Market Report 2023
Single-Chamber Prefilled Syringes Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas
+1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: